Search

Search Constraints

You searched for: Author/Creator William, Basem M.

Search Results

3. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long‐term outcomes. (8th March 2016)

4. Dual institution experience of nodal marginal zone lymphoma reveals excellent long‐term outcomes in the rituximab era. (22nd July 2016)

6. Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non‐Hodgkin lymphoma. (5th December 2018)

7. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. (November 2018)

9. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era. Issue 7 (9th August 2017)